Top News: #Biologics

Here are the top read news for #biologics:


medpagePanel Defines Opportunistic Infections Tied to Biologics:

An international consensus committee has defined the types and presentations of infectious pathogens that could be considered opportunistic infections (OI) within the setting of biologic therapy. Read more


genlogo (1)Managing and Preventing Loss of Response to Biologics:

Although biologics have been game-changing additions to the clinician’s armamentarium for the management of inflammatory bowel disease (IBD), some patients do not achieve an initial response, or relapse following a good response. To help our readers manage these clinically challenging patients, Gastroenterology & Endoscopy News asked several experts to share their approach to the problem Read more


Biologics for Long-Term Treatment of Psoriasis Generally Safe:

A German cohort study in Archives of Dermatological Research found that antipsoriatic drugs for treatment of moderate-to-severe psoriasis are generally safe over the long-term. Read more


Swiss drugmaker Novartis' logo is seen behind scaffolding at the company's plant in the northern Swiss town of Stein January 27, 2015. REUTERS/Arnd WiegmannNovartis biosimilar copycat takes aim at Amgen’s drug Enbrel:

The U.S. Food and Drug Administration has accepted Novartis (NOVN.VX) unit Sandoz’s regulatory submission for approval of a biosimilar copy of Amgen’s (AMGN.O) blockbuster Enbrel drug, the Swiss drugmaker said on Friday. Read more